Skip to main content
. 2023 May 18;30(7):1710–1725. doi: 10.1038/s41418-023-01173-6

Fig. 7. Simvastatin synergises with a dual USP28/25 inhibitor to reduce viability of SCC cells.

Fig. 7

a Human ADC (H1299 and EKXV) and SCC (LUDLU and H2170) cells were treated with different concentrations of simvastatin for 72 h. Cell viability was determined using crystal violet staining. b A431, H2170 and LUDLU cells were treated with indicated concentrations of simvastatin (Sim) or AZ1 in medium containing 1% FCS for 72 h. Drug synergy was calculated using ZIP model. c Working model for the regulation of SREBP2 by USP28. Created with BioRender.com.